IP Verse

Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions - EP2460820

The patent EP2460820 was granted to Boehringer Ingelheim Animal Health USA on Jun 19, 2019. The application was originally filed on Dec 29, 2005 under application number EP12155382A. The patent is currently recorded with a legal status of "Revoked".

EP2460820

BOEHRINGER INGELHEIM ANIMAL HEALTH USA
Application Number
EP12155382A
Filing Date
Dec 29, 2005
Status
Revoked
Nov 26, 2021
Grant Date
Jun 19, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELANCOJan 10, 2020POTTER CLARKSONADMISSIBLE
CEVA SANTE ANIMALEJan 9, 2020CABINET BECKER ET ASSOCIESADMISSIBLE
LABORATORIOS HIPRAJan 8, 2020GRUNECKER PATENTADMISSIBLE

Patent Citations (28) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20050034797
DESCRIPTIONUS2909462
DESCRIPTIONUS6703023
OPPOSITIONAU2005220241
OPPOSITIONCA2784260
OPPOSITIONEP1926496
OPPOSITIONEP2460820
OPPOSITIONGB2282811
OPPOSITIONUS2002106639
OPPOSITIONUS2003170270
OPPOSITIONUS2004161410
OPPOSITIONUS319975
OPPOSITIONUS3479705
OPPOSITIONUS6703023
OPPOSITIONUS7122192
OPPOSITIONWO0001409
OPPOSITIONWO03049703
OPPOSITIONWO2005009462
OPPOSITIONWO2006072065
OPPOSITIONWO2007028823
OPPOSITIONWO2008076915
OPPOSITIONWO9307898
OPPOSITIONWO9418311
OPPOSITIONWO9929717
SEARCHWO0001409
SEARCHWO0077216
SEARCHWO2005009462
SEARCHWO2007028823

Non-Patent Literature (NPL) Citations (35) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ALTSCHUL, S. ET AL., BLAST Manual, NCVI NLM NIH BETHESDA
DESCRIPTION- ALTSCHUL, S. F. ET AL., J. MOLEC. BIOL., (1990), vol. 215, pages 403 - 410
DESCRIPTION- CARILLO, H.; LIPMAN, D.; SIAM J., APPLIED MATH., (1988), vol. 48, page 1073
DESCRIPTION- DEVEREUX, J. ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, no. 1, page 387
DESCRIPTION- HUNTER ET AL., The Theory and Practical Application of Adjuvants, JOHNWILEY AND SONS, NY, (1995), pages 51 - 94
DESCRIPTION- JOURNAL OF GENERAL VIROLOGY, (2000), vol. 81, pages 2281 - 2287
DESCRIPTION- M. POWELL AND M. NEWMAN,, Vaccine Design, The Subunit and Adjuvant Approach, PLENUM PRESS, (1995), page 147
DESCRIPTION- PHAMEUROPA, (199606), vol. 8, no. 2
DESCRIPTION- TODD ET AL., VACCINE, (1997), vol. 15, pages 564 - 570
OPPOSITION- Baculovirus Expression Vector System Instruction Manual, (19990500), XP002621775
OPPOSITION- BOGA et al., J Gen Virol, (19970000), vol. 78, pages 2315 - 2318, XP002450362
OPPOSITION- C. CHARREYRE et al., Proceedings of the 15th IPVS Congress, Birmingham, England, (19980705), vol. 2, page 139, XP055525284
OPPOSITION- Handbook '' Veterinary Vaccinology, (19990000), page 175, 177, 178, XP055670231
OPPOSITION- HUIYING FAN et al, "Baculovirus insect expression and immunological studies of porcin circovirus type 2 capsid protein", Proc. 2nd Asian Pig Vet. Soc. Congress, Philippines, (20050919), pages 186 - 188, XP055292703
OPPOSITION- Michael Haake, Andreas Palzer, Beate Rist, Christiane Weissenbacher-Lang, Vicky Fachinger, Alex Eggen, Mathias Ritzmann, Matthias Eddicks, "Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies", Vet. Microbiol., (20130101), vol. 168, pages 1 - 9, XP055502963
OPPOSITION- NAWAGITGUL et al., J Gen Virol, (20000000), vol. 81, pages 2281 - 2287, XP002978778
OPPOSITION- SCHINKEL et al., Swine Research Report, (20030000), page 57, 61, XP055277371
OPPOSITION- Sofer G, "Virus inactivation in the 1990s - And into the 21st century: Part 4, culture media, biotechnology products, and vaccines", BIOPHARM INTERNATIONAL, ADVANSTAR COMMUNICATIONS, DULUTH, MN, US, US, (20030101), vol. 16, no. 1, ISSN 1542-166X, pages 50 - 52, 54-57, XP009171415
OPPOSITION- WEINGARTL, Agriculture, (20020000), vol. 1, pages 11 - 14, XP055292683
OPPOSITION- WEINGARTL, "Porcine circovirus structure and replication a minireview", Agriculture, (20020000), vol. 1, pages 11 - 14, XP055292683
OPPOSITION- BACHMANN et al., Immunology Today, (19960000), vol. 17, pages 553 - 558, XP004071007
OPPOSITION- LILJEQVIST et al., J. Biotechnol., (19990000), vol. 73, pages 1 - 33, XP004180163
OPPOSITION- RUEDA P. et al, "Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles", Vaccine, ELSEVIER, AMSTERDAM, NL, (20001122), vol. 19, no. 7-8, doi:10.1016/S0264-410X(00)00259-0, pages 726 - 734, XP004225389
OPPOSITION- BLANCHARD et al., "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", Vaccine, (20030000), vol. 21, pages 4565 - 4575, XP004467337
OPPOSITION- BLANCHARD et al., Vaccine, (20030000), vol. 21, pages 4565 - 4575, XP004467337
OPPOSITION- BLANCHARD P. et al, "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", Vaccine, ELSEVIER, AMSTERDAM, NL, (20031107), vol. 21, no. 31, doi:10.1016/S0264-410X(03)00503-6, pages 4565 - 4575, XP004467337
OPPOSITION- FENAUX et al., "A CHIMERIC PORCINE CIRCOVIRUS (PCV) WITH THE IMMUNOGENIC CAPSID GENE FOR THE PATHOGENIC PCV TYPE 2 (PCV2) CLONED INTO THE GENOMIC BACKBONE OF THE NONPATHOGENIC PCV1 INDUCES PROTECTIVE IMMUNITY AGAINST PCV2 INFECTION IN PIGS", Journal of Virology, (20040000), vol. 78, no. 12, pages 6297 - 6303, XP008039321
OPPOSITION- FENAUX et al., Journal of Virology, (20040000), vol. 78, no. 12m, pages 6297 - 6303, XP008039321
OPPOSITION- FENAUX M. ET AL, "A CHIMERIC PORCINE CIRCOVIRUS (PCV) WITH THE IMMUNOGENIC CAPSID GENE FOR THE PATHOGENIC PCV TYPE 2 (PCV2) CLONED INTO THE GENOMIC BACKBONE OF THE NONPATHOGENIC PCV1 INDUCES PROTECTIVE IMMUNITY AGAINST PCV2 INFECTION IN PIGS", JOURNAL OF VIROLOGY, US, (20040601), vol. 78, no. 12, doi:10.1128/JVI.78.12.6297-6303.2004, pages 6297 - 6303, XP008039321
OPPOSITION- YANG et al., "Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice", J Vet Sci, (20050000), vol. 6, pages 125 - 133, XP055670219
SEARCH- FACHINGER ET AL, "The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex", VACCINE, ELSEVIER LTD, GB, (20080301), vol. 26, no. 11, ISSN 0264-410X, pages 1488 - 1499, XP022505432
SEARCH- KIM YUNA ET AL, "Characterization of the recombinant proteins of porcine circovirus type2 field isolate expressed in the baculovirus system", JOURNAL OF VETERINARY SCIENCE, KOREAN SOCIETY OF VETERINARY SCIENCE, SUWON, KR, (20020301), vol. 3, no. 1, ISSN 1229-845X, pages 19 - 23, XP002349036 [A] 1-22 * page 20, column R, paragraph 3 * * figure 4 *
SEARCH- NAWAGITGUL P ET AL, "Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, (20000101), vol. 81, no. 9, ISSN 0022-1317, pages 2281 - 2287, XP002978778 [A] 1-22 * the whole document *
SEARCH- KIXMOLLER M ET AL, "Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2", VACCINE, ELSEVIER LTD, GB, vol. 26, no. 27-28, doi:10.1016/J.VACCINE.2008.04.032, ISSN 0264-410X, (20080625), pages 3443 - 3451, (20080505), XP022710551
SEARCH- BLANCHARD P ET AL, "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, ELSEVIER LTD, GB, (20031107), vol. 21, no. 31, doi:10.1016/S0264-410X(03)00503-6, ISSN 0264-410X, pages 4565 - 4575, XP004467337 [X] 1-4,8,12-15,18-22 * figures 2-4 * * tables 1, 2 * * page 4574, column l, lines 11-14 * [I] 3-7,9-11,16,17

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents